
Bavarian Nordic Struggles to Supply Monkeypox Shot
To meet surging global demand for its Jynneos-branded monkeypox vaccine, Danish biotech Bavarian Nordic (BN) is pulling out all stops. Strategies include outsourcing production of other vaccines to CDMOs and exploring the reuse of millions of doses that have technically expired but are still viable.